Pennsylvania HB 1652: An Act amending the act of September 9, 1965 (P.L.497, No.251), known as the Newborn Child Testing Act, further providing for Newborn Child Screening and Follow-up Program.

Bill Text

PRINTER'S NO. 2005
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 1652
Session of
2025
INTRODUCED BY SALISBURY, McNEILL, HILL-EVANS, KAZEEM, FRANKEL,
SANCHEZ, HANBIDGE, BOROWSKI, FLEMING, CIRESI, RIVERA, WAXMAN,
KHAN, SCHLOSSBERG, T. DAVIS AND D. MILLER, JUNE 24, 2025
REFERRED TO COMMITTEE ON HEALTH, JUNE 24, 2025
AN ACT
Amending the act of September 9, 1965 (P.L.497, No.251),
entitled "An act requiring physicians, hospitals and other
institutions to administer or cause to be administered tests
for genetic diseases upon infants in certain cases," further
providing for Newborn Child Screening and Follow-up Program.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 3(a)(1) of the act of September 9, 1965
(P.L.497, No.251), known as the Newborn Child Testing Act, is
amended by adding a subparagraph to read:
Section 3. Newborn Child Screening and Follow-up Program.--
(a) In order to assist health care providers to determine
whether treatment or other services are necessary to avert
intellectual disability, physical disability or death, the
department, with the approval of the Newborn Screening and
Follow-up Technical Advisory Board, shall establish a program
providing for:
(1) The screening tests of newborn children and follow-up
services for the following diseases:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

* * *
(xi) Gaucher disease.
* * *
Section 2. This act shall take effect in 60 days.
20250HB1652PN2005 - 2 -
1
2
3
4